Retinoids for treatment of retinal diseases

Trends in Pharmacological Sciences

Volumn 31, Issue 6, 2010, Pages 284-295

  Palczewski, Krzysztof ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 CIS RETINAL; 9 CIS RETINYL ACETATE; ABC TRANSPORTER; ABC TRANSPORTER A4; ALITRETINOIN; ALPHA TOCOPHEROL; BETA CAROTENE; CAROTENOID; GENE PRODUCT; ISOTRETINOIN; LECITHIN RETINOL ACYLTRANSFERASE; N RETINYLAMINE; RETINAL; RETINAL PIGMENT EPITHELIUM 65 PROTEIN; RETINOIC ACID; RETINOID; RETINOID DERIVATIVE; RETINOL; RETINOL ESTER; RETINYLAMINE; UNCLASSIFIED DRUG; VISUAL PIGMENT; EYE PROTEIN;

BLINDNESS; CHROMATOPHORE; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG TRANSFORMATION; GENE MUTATION; GENE THERAPY; GENETIC DISORDER; HUMAN; NONHUMAN; PHOTORECEPTOR; PHOTOTRANSDUCTION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA CONE; RETINA DEGENERATION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD; RETINITIS PIGMENTOSA; RETINOL DEFICIENCY; REVIEW; STARGARDT DISEASE; VISUAL ADAPTATION; VISUAL DISORDER; VISUAL IMPAIRMENT; VISUAL STIMULATION; VISUAL SYSTEM FUNCTION; VITAMIN METABOLISM; ANIMAL; BIOLOGICAL MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; GENETICS; METABOLISM; PHOTORECEPTOR CELL; PHYSIOLOGY; PROCEDURES; RETINAL DISEASES; VISION;

ANIMALS; BLINDNESS; DRUG DELIVERY SYSTEMS; EYE PROTEINS; HUMANS; MODELS, BIOLOGICAL; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL DISEASES; RETINALDEHYDE; RETINOIDS; VISION, OCULAR; VISUAL PERCEPTION;

EID: 77953683083     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2010.03.001     Document Type: Review

References (133)

1. Thompson D.A., Gal A. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog. Retinal Eye Res. 2003, 22:683-693.
2. Travis G.H., et al. Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. Annu. Rev. Pharmacol. Toxicol. 2007, 47:469-512.
3. Maeda T., et al. Effects of long-term administration of 9-cis-retinyl acetate on visual function in mice. Invest. Ophthalmol. Vis. Sci. 2009, 50:322-333.
4. Jackson G.R., et al. Impact of aging and age-related maculopathy on inactivation of the α-wave of the rod-mediated electroretinogram. Vision Res. 2006, 46:1422-1431.
5. Yau K.W., Hardie R.C. Phototransduction motifs and variations. Cell 2009, 139:246-264.
6. Arshavsky V.Y., et al. G proteins and phototransduction. Annu. Rev. Physiol. 2002, 64:153-187.
7. McBee J.K., et al. Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina. Prog. Retinal Eye Res. 2001, 20:469-529.
8. Rando R.R. Polyenes and vision. Chem. Biol. 1996, 3:255-262.
9. Lamb T.D., Pugh E.N. Dark adaptation and the retinoid cycle of vision. Prog. Retinal Eye Res. 2004, 23:307-380.
10. Ridge K.D., et al. Phototransduction: crystal clear. Trends Biochem. Sci. 2003, 28:479-487.
11. Ridge K.D., Palczewski K. Visual rhodopsin sees the light: structure and mechanism of G protein signaling. J. Biol. Chem. 2007, 282:9297-9301.
12. Moise A.R., et al. Delivery of retinoid-based therapies to target tissues. Biochemistry 2007, 46:4449-4458.
13. Filipek S., et al. G protein-coupled receptor rhodopsin: a prospectus. Annu. Rev. Physiol. 2003, 65:851-879.
14. Palczewski K. G protein-coupled receptor rhodopsin. Ann. Rev. Biochem. 2006, 75:743-767.
15. von Lintig J., et al. The biochemical and structural basis for trans-to-cis isomerization of retinoids in the chemistry of vision. Trends Biochem. Sci. 2010, 10.1016/j.tibs.2010.01.005.
16. 2+-binding proteins in the retina. Trends Neurosci. 1996, 19:547-554.
17. Jacobson S.G., et al. Human cone photoreceptor dependence on RPE65 isomerase. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:15123-15128.
18. Mata N.L., et al. Isomerization and oxidation of vitamin a in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight. Neuron 2002, 36:69-80.
19. Schonthaler H.B., et al. Evidence for RPE65-independent vision in the cone-dominated zebrafish retina. Eur. J. Neurosci. 2007, 26:1940-1949.
20. Wang J.S., et al. Intra-retinal visual cycle required for rapid and complete cone dark adaptation. Nat. Neurosci. 2009, 12:295-302.
21. Molday R.S. ATP-binding cassette transporter ABCA4: molecular properties and role in vision and macular degeneration. J. Bioenerg. Biomembr. 2007, 39:507-517.
22. Saari J.C., Bredberg D.L. Lecithin:retinol acyltransferase in retinal pigment epithelial microsomes. J. Biol. Chem. 1989, 264:8636-8640.
23. Saari J.C., et al. Retinol esterification in bovine retinal pigment epithelium: reversibility of lecithin:retinol acyltransferase. Biochem. J. 1993, 291:697-700.
24. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996, 10:940-954.
25. Ross A.C. Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic acid oxidation. J. Nutr. 2003, 133:291S-296S.
26. Paik J., et al. Vitamin A: overlapping delivery pathways to tissues from the circulation. J. Nutr. 2004, 134:276S-280S.
27. Blaner W.S., et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 2009, 1791:467-473.
28. Voolstra O., et al. NinaB is essential for Drosophila vision but induces retinal degeneration in opsin-deficient photoreceptors. J. Biol. Chem. 2009, 285:2130-2139.
29. Fierce Y., et al. In vitro and in vivo characterization of retinoid synthesis from beta-carotene. Arch. Biochem. Biophys. 2008, 472:126-138.
30. Moise A.R., et al. Related enzymes solve evolutionarily recurrent problems in the metabolism of carotenoids. Trends Plant Sci. 2005, 10:178-186.
31. Yeum K.J., Russell R.M. Carotenoid bioavailability and bioconversion. Annu. Rev. Nutr. 2002, 22:483-504.
32. Baehr W., Frederick J.M. Naturally occurring animal models with outer retina phenotypes. Vision Res. 2009, 49:2636-2652.
33. -/- mice: a defect that can be corrected by 11-cis retinal. Invest. Ophthalmol. Vis. Sci. 2005, 46:3876-3882.
34. Fan J., et al. Opsin activation of transduction in the rods of dark-reared Rpe65 knockout mice. J. Physiol. 2005, 568:83-95.
35. Hofmann K.P., et al. The role of arrestin and retinoids in the regeneration pathway of rhodopsin. J. Biol. Chem. 1992, 267:15701-15706.
36. Palczewski K., et al. Rod outer segment retinol dehydrogenase: substrate specificity and role in phototransduction. Biochemistry 1994, 33:13741-13750.
37. Jager S., et al. Opsin/all-trans-retinal complex activates transducin by different mechanisms than photolyzed rhodopsin. Biochemistry 1996, 35:2901-2908.
38. Zhang H., et al. Trafficking of membrane-associated proteins to cone photoreceptor outer segments requires the chromophore 11-cis-retinal. J. Neurosci. 2008, 28:4008-4014.
39. Dryja T.P. Doyne Lecture. Rhodopsin and autosomal dominant retinitis pigmentosa. Eye 1992, 6:1-10.
40. Rattner A., et al. Molecular genetics of human retinal disease. Annu. Rev. Genet. 1999, 33:89-131.
41. Weng J., et al. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 1999, 98:13-23.
42. Perrault I., et al. Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis. Nat. Genet. 1996, 14:461-464.
43. Dryja T.P., et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990, 343:364-366.
44. Sokal I., et al. GCAP1 (Y99C) mutant is constitutively active in autosomal dominant cone dystrophy. Mol. Cell 1998, 2:129-133.
45. Baehr W., et al. The retinoid cycle and retina disease. Vision Res. 2003, 43:2957-2958.
46. Imanishi Y., et al. Noninvasive two-photon imaging reveals retinyl ester storage structures in the eye. J. Cell Biol. 2004, 164:373-383.
47. Imanishi Y., et al. Retinosomes: new insights into intracellular managing of hydrophobic substances in lipid bodies. J. Cell Biol. 2004, 166:447-453.
48. Golczak M., et al. Lecithin:retinol acyltransferase is responsible for amidation of retinylamine, a potent inhibitor of the retinoid cycle. J. Biol. Chem. 2005, 280:42263-42273.
49. Fotiadis D., et al. The G protein-coupled receptor rhodopsin in the native membrane. FEBS Lett. 2004, 564:281-288.
50. Fotiadis D., et al. Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 2003, 421:127-128.
51. Liang Y., et al. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 2003, 278:21655-21662.
52. Govardovskii V.I., et al. Lateral diffusion of rhodopsin in photoreceptor membrane: a reappraisal. Mol. Vis. 2009, 15:1717-1729.
53. Corless J.M., et al. Two-dimensional rhodopsin crystals from disk membranes of frog retinal rod outer segments. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:1116-1120.
54. Corless J.M., et al. Three-dimensional membrane crystals in amphibian cone outer segments. 1. Light-dependent crystal formation in frog retinas. J. Struct. Biol. 1994, 113:64-86.
55. Nickell S., et al. Three-dimensional architecture of murine rod outer segments determined by cryoelectron tomography. J. Cell Biol. 2007, 177:917-925.
56. Maeda A., et al. Retinol dehydrogenase (RDH12) protects photoreceptors from light-induced degeneration in mice. J. Biol. Chem. 2006, 281:37697-37704.
57. Wenzel A., et al. The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration. J. Neurosci. 2001, 21:53-58.
58. Maeda A., et al. Retinopathy in mice induced by disrupted all-trans-retinal clearance. J. Biol. Chem. 2008, 283:26684-26693.
59. Mata N.L., et al. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7154-7159.
60. Kim S.R., et al. Characterization of dihydro-A2PE: an intermediate in the A2E biosynthetic pathway. Biochemistry 2007, 46:10122-10129.
61. Fishkin N.E., et al. Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7091-7096.
62. Yannuzzi L.A., et al. Ophthalmic fundus imaging: today and beyond. Am. J. Ophthalmol. 2004, 137:511-524.
63. Finnemann S.C., et al. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3842-3847.
64. Kim S.R., et al. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp. Eye Res. 2006, 82:828-839.
65. Kim S.R., et al. Mechanisms involved in A2E oxidation. Exp. Eye Res. 2008, 86:975-982.
66. Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am. J. Hum. Genet. 2000, 67:487-491.
67. Allikmets R., et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997, 277:1805-1807.
68. Cremers F.P., et al. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. Hum. Mol. Genet. 1998, 7:355-362.
69. Martinez-Mir A., et al. Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR. Nat. Genet. 1998, 18:11-12.
70. Zhang L., et al. Expression of functional G protein-coupled receptors in photoreceptors of transgenic Xenopus laevis. Biochemistry 2005, 44:14509-14518.
71. Parish C.A., et al. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14609-14613.
72. Delori F.C., et al. In vivo measurement of lipofuscin in Stargardt's disease - fundus flavimaculatus. Invest. Ophthalmol. Vis. Sci. 1995, 36:2327-2331.
73. Maeda A., et al. Involvement of all-trans-retinal in acute light-induced retinopathy of mice. J. Biol. Chem. 2009, 284:15173-15183.
74. Radu R.A., et al. Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5928-5933.
75. De S., Sakmar T.P. Interaction of A2E with model membranes. Implications to the pathogenesis of age-related macular degeneration. J. Gen. Physiol. 2002, 120:147-157.
76. Allikmets R., et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat. Genet. 1997, 15:236-246.
77. Rattner A., et al. Identification and characterization of all-trans-retinol dehydrogenase from photoreceptor outer segments, the visual cycle enzyme that reduces all-trans-retinal to all-trans-retinol. J. Biol. Chem. 2000, 275:11034-11043.
78. Chiu H.J., et al. Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation. FASEB J. 2008, 22:3878-3887.
79. O'Connell M.J., et al. Retro-retinoids in regulated cell growth and death. J. Exp. Med. 1996, 184:549-555.
80. Moise A.R., et al. Metabolism and transactivation activity of 13,14-dihydroretinoic acid. J. Biol. Chem. 2005, 280:27815-27825.
81. Moise A.R., et al. Stereospecificity of retinol saturase: absolute configuration, synthesis, and biological evaluation of dihydroretinoids. J. Am. Chem. Soc. 2008, 130:1154-1155.
82. Ziouzenkova O., et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat. Med. 2007, 13:695-702.
83. Acland G.M., et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol. Ther. 2005, 12:1072-1082.
84. Acland G.M., et al. Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. 2001, 28:92-95.
85. Bainbridge J.W., et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 2008, 358:2231-2239.
86. Maguire A.M., et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 2008, 358:2240-2248.
87. Cideciyan A.V., et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15112-15117.
88. Imanishi, Y. and Palczewski, K. Visualization of retinoid storage and trafficking by two-photon microscopy. Methods Mol. Biol. (in press).
89. Imanishi Y., et al. Retinyl ester homeostasis in the adipose differentiation-related protein-deficient retina. J. Biol. Chem. 2008, 283:25091-25102.
90. Hanein S., et al. Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum. Mutat. 2004, 23:306-317.
91. Van Hooser J.P., et al. Recovery of visual functions in a mouse model of Leber congenital amaurosis. J. Biol. Chem. 2002, 277:19173-19182.
92. Fan J., et al. Isorhodopsin rather than rhodopsin mediates rod function in RPE65 knock-out mice. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13662-13667.
93. Batten M.L., et al. Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis. PLoS Med. 2005, 2:e333.
94. Li T., et al. Effect of vitamin A supplementation on rhodopsin mutants threonine-17→methionine and proline-347→serine in transgenic mice and in cell cultures. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:11933-11938.
95. Radu R.A., et al. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation. Invest. Ophthalmol. Vis. Sci. 2008, 49:3821-3829.
96. Noorwez S.M., et al. Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J. Biol. Chem. 2003, 278:14442-14450.
97. Ablonczy Z., et al. 11-cis-Retinal reduces constitutive opsin phosphorylation and improves quantum catch in retinoid-deficient mouse rod photoreceptors. J. Biol. Chem. 2002, 277:40491-40498.
98. Jackson G.R., et al. Aging and dark adaptation. Vision Res. 1999, 39:3975-3982.
99. Gao H., Hollyfield J.G. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci 1992, 33:1-17.
100. Jackson G.R., et al. Aging and scotopic sensitivity. Vision Res. 1998, 38:3655-3662.
101. Berson E.L., et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch. Ophthalmol. 1993, 111:761-772.
102. Katz M.L., Redmond T.M. Effect of Rpe65 knockout on accumulation of lipofuscin fluorophores in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2001, 42:3023-3030.
103. Jacobson S.G., et al. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat. Genet. 1995, 11:27-32.
104. Schoeff L. Vitamin A. Am. J. Med. Technol. 1983, 49:447-452.
105. Birnbach C.D., et al. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology 1994, 101:1211-1219.
106. De Laey J.J., Verougstraete C. Hyperlipofuscinosis and subretinal fibrosis in Stargardt's disease. Retina 1995, 15:399-406.
107. Lois N., et al. Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am. J. Ophthalmol. 2002, 133:341-349.
108. Bindewald A., et al. Classification of fundus autofluorescence patterns in early age-related macular disease. Invest. Ophthalmol. Vis. Sci. 2005, 46:3309-3314.
109. Delori F.C., et al. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest. Ophthalmol. Vis. Sci. 2001, 42:1855-1866.
110. Wabbels B., et al. Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Albrecht von Graefes Arch. Klin. Exp. Ophthalmol. 2006, 244:36-45.
111. Zhang K., et al. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat. Genet. 2001, 27:89-93.
112. Karan G., et al. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4164-4169.
113. Golczak M., et al. Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8162-8167.
114. Maeda A., et al. Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice. Mol. Pharmacol. 2006, 70:1220-1229.
115. Maeda A., et al. Aberrant metabolites in mouse models of congenital blinding diseases: formation and storage of retinyl esters. Biochemistry 2006, 45:4210-4219.
116. Tu D.C., et al. Inner retinal photoreception independent of the visual retinoid cycle. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10426-10431.
117. Golczak M., et al. Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina. J. Biol. Chem. 2008, 283:9543-9554.
118. Maeda T., et al. Loss of cone photoreceptors caused by chromophore depletion is partially prevented by the artificial chromophore pro-drug, 9-cis-retinyl acetate. Hum. Mol. Genet. 2009, 18:2277-2287.
119. Radu R.A., et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest. Ophthalmol. Vis. Sci. 2005, 46:4393-4401.
120. Radu R.A., et al. Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Novartis Found. Symp. 2004, 255:51-63. (discussion 63-57, 177-178).
121. Radu R.A., et al. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4742-4747.
122. Law W.C., Rando R.R. The molecular basis of retinoic acid induced night blindness. Biochem. Biophys. Res. Commun. 1989, 161:825-829.
123. -/- mouse at early ages. Invest. Ophthalmol. Vis. Sci. 2005, 46:1473-1479.
124. -/- mice: comparable models of Leber congenital amaurosis. Invest. Ophthalmol. Vis. Sci. 2008, 49:2384-2389.
125. Rodieck R.W. The First Steps in Seeing 1998, Sinauer Associates.
126. Jacobson S.G., et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6177-6182.
127. Wing G.L., et al. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1978, 17:601-607.
128. Rattner A., Nathans J. Macular degeneration: recent advances and therapeutic opportunities. Nat. Rev. Neurosci. 2006, 7:860-872.
129. Sparrow J.R., et al. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest. Ophthalmol. Vis. Sci. 1999, 40:2988-2995.
130. Eldred G.E. Age pigment structure. Nature 1993, 364:396.
131. Yasukawa T., et al. Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits. Albrecht von Graefes Arch. Klin. Exp. Ophthalmol. 2007, 245:1475-1485.
132. Vives-Bauza C., et al. The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells. J. Biol. Chem. 2008, 283:24770-24780.
133. Sparrow J.R., et al. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci. 2000, 41:1981-1989.